REPORTS

Let’s Pullulate and Expand Your Business

Targeted Cancer Drugs Market - Global Professional Analysis and Forecast to 2026

Mar 04, 2020  |  220 PAGES  |  REPORT CODE: CMM270028
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Targeted Cancer Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

This report presents the market size and development trends by detailing the Targeted Cancer Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Targeted Cancer Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Targeted Cancer Drugs industry and will help you to build a panoramic view of the industrial development.

Targeted Cancer Drugs Market, By Type:

  • Cancer Growth Blocker Drug

  • Monoclonal Antibody

  • Other

Targeted Cancer Drugs Market, By Application:

  • Hospitals

  • Academic & Research Institutes

  • Diagnostic & Reference Laboratories

Some of the leading players are as follows:

  • Gilead

  • Astellas Pharma

  • Novartis

  • Celgene

  • Galapagos

  • Pfizer

  • Vertex

  • Eli Lilly

  • Sanofi

  • Incyte

  • AbbVie

  • Teva

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Targeted Cancer Drugs Market: Technology Type Analysis

  • 4.1 Targeted Cancer Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Targeted Cancer Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Cancer Growth Blocker Drug

    • 4.3.2 Monoclonal Antibody

    • 4.3.3 Other

5 Targeted Cancer Drugs Market: Product Analysis

  • 5.1 Targeted Cancer Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 Targeted Cancer Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Targeted Cancer Drugs Market: Application Analysis

  • 6.1 Targeted Cancer Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 Targeted Cancer Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Academic & Research Institutes

    • 6.3.3 Diagnostic & Reference Laboratories

7 Targeted Cancer Drugs Market: Regional Analysis

  • 7.1 Targeted Cancer Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 Targeted Cancer Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Gilead

    • 9.1.1 Gilead Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Astellas Pharma

    • 9.2.1 Astellas Pharma Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis

    • 9.3.1 Novartis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Celgene

    • 9.4.1 Celgene Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Galapagos

    • 9.5.1 Galapagos Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Pfizer

    • 9.6.1 Pfizer Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Vertex

    • 9.7.1 Vertex Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Eli Lilly

    • 9.8.1 Eli Lilly Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Sanofi

    • 9.9.1 Sanofi Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Incyte

    • 9.10.1 Incyte Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 AbbVie

    • 9.11.1 AbbVie Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Teva

    • 9.12.1 Teva Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

 

The List of Tables and Figures (Totals 88 Figures and 122 Tables)

  • Figure Cancer Growth Blocker Drug Targeted Cancer Drugs market, 2015 - 2026 (USD Million)

  • Figure Monoclonal Antibody Targeted Cancer Drugs market, 2015 - 2026 (USD Million)

  • Figure Other Targeted Cancer Drugs market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Academic & Research Institutes market, 2015 - 2026 (USD Million)

  • Figure Diagnostic & Reference Laboratories market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Targeted Cancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe Targeted Cancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Targeted Cancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Targeted Cancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA Targeted Cancer Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Targeted Cancer Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Targeted Cancer Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Targeted Cancer Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Gilead Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Celgene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Galapagos Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vertex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Incyte Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top